Filing Details

Accession Number:
0000874015-13-000106
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-23 19:39:17
Reporting Period:
2013-09-19
Filing Date:
2013-09-23
Accepted Time:
2013-09-23 19:39:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Isis Pharmaceuticals Inc ISIS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897667 T Stanley Crooke C/O Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-19 20,000 $11.12 21,661 No 4 M Direct
Common Stock Disposition 2013-09-19 20,000 $35.12 1,661 No 4 S Direct
Common Stock Acquisiton 2013-09-19 30,000 $11.12 31,661 No 4 M Direct
Common Stock Disposition 2013-09-19 30,000 $35.02 1,661 No 4 S Direct
Common Stock Acquisiton 2013-09-20 8,740 $11.12 10,401 No 4 M Direct
Common Stock Disposition 2013-09-20 8,740 $35.90 1,661 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-09-19 50,000 $0.00 50,000 $11.12
Common Stock Employee Stock Option (right to buy) Disposition 2013-09-20 8,740 $0.00 8,740 $11.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,740 2011-01-02 2014-01-01 No 4 M Direct
0 2011-01-02 2014-01-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 174 Indirect By Wife
Common Stock 725,391 Indirect By Trust
Footnotes
  1. Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/14. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 6/27/2012.